I don’t have any problem at all with your critiques of the Company, it’s the childish personal attacks we can do without.
Most of us here have been invested at a much lower average than the current price, but yes no updates and constant pushback of trials are testing my patience.
I would remind you that when InMed reached those levels last January the expectation was that clinical trials would begin in spring of 2018. That expectation was set back by a year months ago. I expect we'll have a similar uptick again this coming January.